A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: The empirical basis for U.S. clinical practice-Reference-Cited by-同舟云学术

A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: The empirical basis for U.S. clinical practice

Published:2009-08 Issue:4 Volume:13 Page:265-274
ISSN:1087-0792
Container-title:Sleep Medicine Reviews
language:en
Short-container-title:Sleep Medicine Reviews

Author:

Krystal Andrew D.

Publisher

Elsevier BV

Subject

Physiology (medical),Clinical Neurology,Neurology,Pulmonary and Respiratory Medicine

Reference117 articles.

1. Drugs used to treat insomnia in 2002: regulatory-based rather than evidence-based medicine;Walsh;Sleep,2004

2. Subjective hypnotic efficacy of trazodone and zolpidem in DSM-III-R primary insomnia;Walsh;Hum Psychopharmacol,1998

3. The changing perspective of chronic insomnia management;Krystal;J Clin Psychiatry,2004

4. Prevalence of insomnia in elderly general practice attenders and the current treatment modalities;Hohagen;Acta Psychiatr Scand,1994

5. Prevalence and treatment of insomnia in general practice. A longitudinal study;Hohagen;Eur Arch Psychiatry Clin Neurosci,1993

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Potential Link between Myeloperoxidase Modified LDL, Atherosclerosis and Depression;International Journal of Molecular Sciences;2024-08-13

2. Insomnia: An Update on Epidemiology, Diagnosis and Non-pharmacological Management;Indian Journal of Sleep Medicine;2024-06-19

3. Activation of GABA type A receptor is involved in the anti-insomnia effect of Huanglian Wendan Decoction;Frontiers in Pharmacology;2024-05-23

4. Sleep disturbance in Angelman syndrome patients;Orphanet Journal of Rare Diseases;2024-04-05

5. UK Medical Cannabis Registry: Assessment of clinical outcomes in patients with insomnia;Brain and Behavior;2024-02